Immuno-modulation with lifestyle behaviour change to reduce SARS-CoV-2 susceptibility and COVID-19 severity: goals consistent with contemporary physiotherapy practiceShow others and affiliations
2022 (English)In: Physiotherapy, ISSN 0031-9406, E-ISSN 1873-1465, Vol. 114, p. 63-67Article in journal (Refereed) Published
Abstract [en]
Lifestyle-related non-communicable diseases (NCDs) and their risk factors are unequivocally associated with SARS-CoV-2 susceptibility and COVID-19 severity. NCD manifestations and their lifestyle risks are associated with chronic low-grade systemic inflammation (CLGSI). This review supports that immuno-modulation with positive lifestyle change aimed at reducing SARS-CoV-2 susceptibility and COVID-19 severity, is a goal consistent with contemporary physiotherapy practice. Physiotherapists have a long tradition of managing a , thus, managing CLGSI is a logical extension. Improving patients' lifestyle practices also reduces their NCD risks and increases activity/exercise capacity, health and wellbeing - all principal goals of contemporary physiotherapy. The COVID-19 pandemic lends further support for prioritising health and lifestyle competencies including smoking cessation; whole food plant-based nutrition; healthy weight; healthy sleep practices; and stress management; in conjunction with reducing sedentariness and increasing physical activity/exercise, to augment immunity as well as function and overall health and wellbeing. To support patients' lifestyle change efforts, physiotherapists may refer patients to other health professionals. The authors conclude that immuno-modulation with lifestyle behaviour change to reduce susceptibility to viruses including SARS-CoV-2, is consistent with contemporary physiotherapy practice. Immuno-modulation needs to be reflected in health competencies taught in physiotherapy professional education curricula and taught at standards comparable to other established interventions.(c) 2021 The Author(s).
Place, publisher, year, edition, pages
ELSEVIER SCI LTD , 2022. Vol. 114, p. 63-67
Keywords [en]
Chronic low-grade systemic inflammation, COVID-19, Disease prevention, Health promotion, Non-communicable diseases, SARS-CoV-2
National Category
Medical and Health Sciences Infectious Medicine
Identifiers
URN: urn:nbn:se:mdh:diva-58160DOI: 10.1016/j.physio.2021.08.006ISI: 000782315700008PubMedID: 34563382Scopus ID: 2-s2.0-85115660413OAI: oai:DiVA.org:mdh-58160DiVA, id: diva2:1655939
2022-05-042022-05-042022-06-07Bibliographically approved